Status:
TERMINATED
Cardiovascular Implications of COVID-19
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
SARS-CoV 2
SARS Pneumonia
Eligibility:
All Genders
18-80 years
Brief Summary
At the end of December of 2019, a series of patients in Wuhan, China were struck with a mysterious respiratory infection. These isolated events have rapidly grown into a deadly, global pandemic. This ...
Detailed Description
This will be a cross-sectional cohort study of participants who will undergo a detailed cardiovascular imaging evaluation and blood draw once they have recuperated from a prior index-hospitalization a...
Eligibility Criteria
Inclusion
- Men and non-pregnant women 18-80 years old who were previously hospitalized with confirmed COVID-19
- Were alive at the time of discharge from COVID-19 hospitalization
- Had measured hs-cTnT levels during hospitalization
Exclusion
- Prior cardiovascular disease (before COVID-19 infection), defined as self-reported history or electronic medical record diagnosis of cardiac arrest, myocardial infarction, coronary revascularization, heart failure, or stroke prior to COVID-19 hospitalization
- Urgent-coronary revascularization or type I myocardial infarction within the preceding 30 days
- Cardiac transplantation
- Body weight \>250 lbs
- Moderate to severe chronic renal dysfunction defined by an eGFR ≤30 mL/min/1.73 m2
- Inability to safely undergo a CMR
- Unwilling or unable to provide informed consent
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04435457
Start Date
September 1 2020
End Date
May 20 2023
Last Update
May 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390